Supplementary Figure S5 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1Suchitra Natarajan, Xin Yu, Ling Li et al.|Unknown|2026Cited by 0
Supplementary Figure S2 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1Suchitra Natarajan, Xin Yu, Khoa Nguyen et al.|Unknown|2026Cited by 0
Figure S1 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1Suchitra Natarajan, Xin Yu, Heyuan Li et al.|Unknown|2026Cited by 0
Supplementary Table S2 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1Suchitra Natarajan, Xin Yu, Khoa Dang P. Nguyen et al.|Unknown|2026Cited by 0
Supplementary Figure S6 from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1Suchitra Natarajan, Xin Yu, Khoa Nguyen et al.|Unknown|2026Cited by 0